`Q5145` Inj, abrilada, 1 mg

Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 160 units per day (practitioner), rationale: Prescribing Information